Capsaicin for allergic rhinitis in adults

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 3, 2006, Pages

  Cheng, Jing ^a   Yang, Xiang Ning ^a   Liu, Xian ^b   Zhang, Shi Ping ^c  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HAY FEVER; HUMAN; PERENNIAL RHINITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; CAPSAICIN; HUMANS; RANDOMIZED CONTROLLED TRIALS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 33745046862     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004460.pub2     Document Type: Review

References (27)

1. Gerth Van Wijk R, Terreehorst IT, Mulder PG, Garrelds IM, Blom HM, Popering S. Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite. A placebo-controlled study. Clinical and Experimental Allergy 2000;30:1792-8.
2. Ciabatti PG, D'Ascanio L. Intranasal capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial. Acta Oto-Laryngologica 2009;129(4):367-71.
3. Ge HQ. Clinical study of CAP in the treatment of perennial allergic rhinitis. Zhong Guo Chang Kuang Yi Xue 2001;14:187-8.
4. He R, Chen YG, Guo X. Clinical study of CAP in the treatment of perennial allergic rhinitis. Si Chuan Yi Xue 2003;24:1238-9.
5. Liu K, Luo Y. Clinical study of capsaicin in the treatment of 53 cases patients with allergic rhinitis. Xian Dai Yi Yao Wei Sheng 2003;19:1658.
6. Liu JJ, Qu SP, Nan ZY. Clinical study of CAP plus incision of anterior ethmoid nerve in the treatment of perennial allergic rhinitis. Chinese Journal of Otorhinolaryngology of Integrated Traditional and Western Medicine 2004;12:89.
7. Sanico AM, Philip G, Proud D, Naclerio RM, Togias A. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clinical and Experimental Allergy 1998;28(1):92-100.
8. Stjarne P, Rinder J, Heden-Blomquist E, Cardell LO, Lundberg J, Zetterstrom O, et al. Capsaicin desensitization of the nasal mucosa reduces symptoms upon allergen challenge in patients with allergic rhinitis. Acta Oto-Laryngologica 1998;118:235-9.
9. Zhang RX, Jiang DS, Li ZJ, Zhou SM, Ding JC, Qiao DB, et al. Clinical observation and therapeutic mechanism of blocking agent of substance P nerves in the treatment of perennial allergic rhinitis. Zhonghua Er Bi Yan Hou Ke Za Zhi 1995;30:163-5.
10. Zhang FY, Zhu XN, Han DM, Wang H, Wang LY. Clinical study of capsaicin in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke Za Zhi 1999;13:499-500.
11. Comparative study of Sinol and Sinol-M in patients with congestion due to allergic rhinitis (SMAN). http://clinicaltrials.gov/ (accessed 8 December 2009).
12. Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections and residential characteristics. Allergy 1996;51:232-7.
13. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.
14. Bousquet J, van Cauwenberge P, Khalaer N. Allergic rhinitis and its impact on asthma. Journal of Allergy and Clinical Immunology 2001;108(Suppl 15):s147-s334.
15. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. Journal of Allergy and Clinical Immunology 1995;96:971-9.
16. Gerth van Wijk RG, deGraaf-int Veld C, Garreids IM. Nasal hyperresponsiveness. Rhinology 1999;37:50-5.
17. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
18. International Rhinitis Management Working Group. International consensus report on diagnosis and management of rhinitis. Allergy 1994;49 (Suppl 19):1-34.
19. Jadad AR, Moore A, Carrol D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
20. Lacroix JS, Buvelot JM, Polla BS, Lundberg JM. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clinical and Experimental Allergy 1991;21:595-600.
21. Lebel BB, Morel J, Chanal A, Godard I, Michel PFB. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. Journal of Allergy and Clinical Immunology 1988;82:869-77.
22. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
23. Ricca V, Landi M, Ferrero P, Bairo A, Tazzer C, Canonica GW, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology 2000;105:54-7.
24. Sanico AM, Atsuta S, Proud D, Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. Journal of Allergy and Clinical Immunology 1997;100:632-41.
25. Sanico AM, Atsuta S, Proud D, Togias A. Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis. Journal of Applied Physiology 1998;84:537-43.
26. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection and diagnosis. Journal of Allergy and Clinical Immunology 2001;108:s2-s8.
27. Togias A. Unique mechanistic features of allergic rhinitis. Journal of Allergy and Clinical Immunology 2000;105:S599-604.